- Home
- BZFD vs SCYX Comparison
BZFD vs SCYX Comparison
Compare BZFD & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZFD | SCYX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 32.6M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BZFD | SCYX |
|---|---|---|
| Price | $0.82 | $0.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 214.1K | ★ 555.8K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $184,927,000.00 | $2,932,000.00 |
| Revenue This Year | $0.51 | $170.77 |
| Revenue Next Year | N/A | $286.38 |
| P/E Ratio | $289.48 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.77 | $0.57 |
| 52 Week High | $2.68 | $1.31 |
Technical Indicators
Market Signals| Indicator | BZFD | SCYX |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 59.20 |
| Support Level | $0.78 | $0.77 |
| Resistance Level | $0.89 | $0.84 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 22.62 | 69.52 |
Price Performance
Historical ComparisonAbout BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.